Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)-

Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)- Struktur
1013098-90-2
CAS-Nr.
1013098-90-2
Englisch Name:
Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)-
Synonyma:
PI3KαPI3Kα/mTOR-IN-1;PI3Kα/mTOR-IN-1;PI3Kα/mTORIN1,PI3Kα/mTOR IN 1,PI-3Kα/mTOR-IN-1;Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)-
CBNumber:
CB63339703
Summenformel:
C16H18N6O
Molgewicht:
310.35
MOL-Datei:
1013098-90-2.mol

Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)- Eigenschaften

Siedepunkt:
637.3±65.0 °C(Predicted)
Dichte
1.422±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
Soluble in DMSO
pka
13.59±0.50(Predicted)

Sicherheit

Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
MedChemexpress LLC 021-58955995
sales@medchemexpress.cn United States 4863 58
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057
3003855609@qq.com China 7892 56
BOC Sciences --
info@bocsci.com USA 0 65
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24131 58

  • Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrazol-4-yl)-
  • PI3Kα/mTOR-IN-1
  • PI3K&alpha
  • PI3Kα/mTOR-IN-1
  • PI3Kα/mTORIN1,PI3Kα/mTOR IN 1,PI-3Kα/mTOR-IN-1
  • 1013098-90-2
Copyright 2019 © ChemicalBook. All rights reserved